However, both reviews note that the findings should be interpreted with a grain of salt due to small sample sizes.21 22 In contrast to those findings, a placebo-controlled trial from early 2025 with over 1,000 subjects found no clear evidence that TA-1 decreased 28-day all-cause mortality in adults with sepsis.23 This ultimately means that more well-designed large-scale trials are needed to determine whether or not TA-1 can actually reduce mortality from sepsis
Antioxidants (Basel) , 10(3), 364
As stated above, they are not a magic bullet lifestyle changes, including diet and exercise, need to be included in the overall regimen for each patient to ensure the outcomes are optimized
doi: 10.3390/ijms24044004 167 XiongJChenXZhaoZLiaoYZhouTXiangQJEet al
Figure 1 shows the average likelihood rating for each food system player across participants with and without GLP-1 medication experience
CNS Neurosci Ther 18:4146